You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mk-2206

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Locally Advanced or Metastatic Solid Tumors Trial (MK-2206, AZD6244)

Completed
Has Results
  • Locally Advanced or Metastatic Solid Tumors
  • (no location specified)
Nov 3, 2017

PANCREAS, Neuroendocrine Trial in New York (MK-2206)

Completed
Has Results
  • PANCREAS
  • Neuroendocrine
  • MK-2206
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2016

Colon Cancer, Rectal Cancer Trial in New York (MK-2206)

Terminated
Has Results
  • Colon Cancer
  • Rectal Cancer
  • MK-2206
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 17, 2015

Advanced Solid Tumors, Tumors, Cancer Trial in San Francisco (MK-2206, Paclitaxel, Trastuzumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +2 more
  • MK-2206
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 27, 2014

Metastatic Breast Cancer Trial (MK-2206, Exemestane, Goserelin)

Withdrawn
  • Metastatic Breast Cancer
  • MK-2206
  • +2 more
  • (no location specified)
Aug 18, 2013